Research

Drugs screened for effects on key transporters, risk of dangerous interactions

Tue Nov 8, 2011

UCSF scientists are studying key drug transporters that play roles in drug absorption and elimination. Shown here: OCT2 and others in the membrane of cells in the kidney tubules (at right). The urine collecting tubules interface with capillaries (at left) to remove substances such as medications and environmental toxins from the blood.

To reduce the risk of toxic drug interactions, UCSF's Kathy Giacomini, PhD, and colleagues are screening thousands of prescription drugs, testing how much they inhibit key proteins in kidney and liver cell

In-flight programming features bioartificial kidney

Fri Oct 21, 2011

BriYYZ

, CC BY-SA 2.0

Passengers who travel on American Airlines from September through October 2011 will learn about the surgically implantable bioartificial kidney being developed at UCSF as a permanent solution to end stage renal disease.

Fischbach receives Packard Fellowship

Mon Oct 17, 2011

Michael Fischbach, PhD

Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.

Huang receives NIH New Innovator Award

Wed Oct 12, 2011

Bo Huang, PhD

Bo Huang, PhD, a faculty member of the UCSF School of Pharmacy, Department of Pharmaceutical Chemistry, has been named a recipient of a 2011 National Institutes of Health (NIH) Director’s New Innovator Award.

Giacomini cites increasing impact of quantitative pharmacology

Mon Oct 10, 2011

Kathy Giacomini, PhD

Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department

Abate aided by QB3’s Startup in a Box program

Wed Sep 28, 2011

Adam Abate, PhD

Adam Abate, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine, Department of Bioengineering and Therapeutic Sciences, is a prime trial candidate for QB3’s Startup in a Box.

Drug information resources may miss parts of boxed warnings

Wed Sep 28, 2011

An analysis by UCSF faculty members from the Schools of Pharmacy and Medicine has found that the half-dozen most reputable electronic drug information resources—tools commonly used by clinicians to make prescription and patient monitoring decisions—may not provide key elements of some medications’...

UCSF Center for Quantitative Pharmacology kicks off with 2-day Mission Bay symposium

Fri Sep 16, 2011

William J. Rutter Center at UCSF Mission Bay

The new UCSF Center for Quantitative Pharmacology housed within the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the Schools of Pharmacy and Medicine, will be inaugurated next week with a wide-ranging, 2-day conference, September 22 and 23, 2011 at William J. ...

Asthma genetics study finds new gene

Mon Aug 29, 2011

niallkennedy

, CC BY-NC 2.0

A novel gene associated with the asthma susceptibility in African Americans was revealed by a U.S. consortium of asthma genetics researchers, including Esteban G. Burchard, MD, MPH, Department of Bioengineering and Therapeutic Sciences,

School of Pharmacy biotech symposium features case histories of future pharmaceuticals

Tue Aug 9, 2011

, UC Regents

The 2nd Annual Bay Area Biotechnology Symposium, presented by the UCSF School of Pharmacy’s Industry Outreach Program in coordination with the UCSF Postdoctoral Scholars Association at Mission Bay in late May 2011, fully lived up to its billing: “Pharmaceuticals of the Futur

Categories: Research